A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers

A comparative analysis and guidance for individualized chemotherapy of stage II and III colorectal cancer patients based on pathological markers

Adjuvant chemotherapy is considered the standard of care for patients with colorectal cancer after curative resection. Although current guidelines provide clear instructions for chemotherapy for stage II high-risk and stage III colorectal cancer, it is insufficient to individualize therapy. We analy...

Full description

Bibliographic Details
Main Authors: Han, Yang, Lu, Su, Yu, Fudong, Liu, Xisheng, Sun, Huimin, Wang, Jingtao, Zhu, Xingwu, Lu, Huijun, Yue, Hao, Wang, Jing, Lin, Jun, Zhou, Chongzhi, Tang, Huamei, Peng, Zhihai
Format: Online
Language:English
Published: Nature Publishing Group 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109035/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5109035/

Similar Items